Figure 1
From: Biomarkers on melanoma patient T Cells associated with ipilimumab treatment
a: Kaplan-Meier relapse-free survival curves comparing patients with (high) greater than median baseline % of EOMES+CD8+to patients with (low) less than median % of EOMES+CD8+. b, Kaplan-Meier relapse-free survival curves comparing patients with high baseline % of Ki67+ EOMES+/CD8+ to patients with low % of Ki67+EOMES+/CD8+.